BRIEF-NuVasive receives FDA 510(k)clearance
September 19, 2016 at 07:25 AM EDT
* Receives FDA 510(k) clearance reinforcing comprehensive portfolio supporting pediatric, adolescent and adult spinal deformity patients Source text for Eikon: Further company coverage:
